Literature DB >> 16952037

Usefulness of preoperative FDG-PET for detection of gastric cancer.

Kota Mukai1, Yasuhiko Ishida, Kunio Okajima, Hiroshi Isozaki, Tsukasa Morimoto, Shoji Nishiyama.   

Abstract

BACKGROUND: Positron emission tomography (PET), using 18F-fluoro-2-deoxy-D-glucose (FDG) as a tracer, can detect malignant neoplasms with altered glucose metabolism. To clarify the usefulness of FDG-PET for detecting gastric cancer, we evaluated preoperative PET imaging in gastric cancer patients.
METHODS: Sixty-two gastric cancer patients who underwent FDG-PET imaging and gastric resection with lymphadenectomy were evaluated.
RESULTS: For primary tumor assessment by PET, detection rates were significantly different in the following order: tumor size 30 mm or more (76.7%) > tumor size less than 30 mm (16.8%); advanced gastric cancer (AGC, 82.9%) > early gastric cancer (EGC; 25.9%); with nodal involvement (79.3%) > without nodal involvement (39.4%). In EGCs, the detection rate of the intestinal type, according to Lauren's classification (43.8%) was significantly higher than that of the diffuse type (0%). Two of the 7 EGC patients who were PET-positive had nodal involvement and their tumors were the intestinal type. For the assessment of nodal involvement, the accuracy of nodal involvement detection was 67.7% with PET and 75.8% with computed tomography (CT). Preoperative FDG-PET revealed colon cancer in 2 patients, adrenal tumor in 1 patient, lung cancer in 1 patient, and lung metastasis in 1 patient.
CONCLUSION: Larger or more advanced tumors with nodal involvement had a higher detection rate by PET. In EGCs, only the intestinal type was detectable by PET. PET-positive EGC may be aggressive, and an adequate lymphadenectomy must be done. Preoperative PET was useful for the detection of other malignancies and distant metastasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952037     DOI: 10.1007/s10120-006-0374-7

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  13 in total

1.  An analysis of the physiological FDG uptake pattern in the stomach.

Authors:  Hirofumi Koga; Masayuki Sasaki; Yasuo Kuwabara; Kiyohisa Hiraka; Makoto Nakagawa; Koichiro Abe; Koichiro Kaneko; Kazutaka Hayashi; Hiroshi Honda
Journal:  Ann Nucl Med       Date:  2003-12       Impact factor: 2.668

2.  Comparison of intratumoral distribution of 99mTc-MIBI and deoxyglucose in mouse breast cancer models.

Authors:  H Ohira; K Kubota; N Ohuchi; Y Harada; H Fukuda; S Satomi
Journal:  J Nucl Med       Date:  2000-09       Impact factor: 10.057

3.  Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.

Authors:  P Flamen; A Lerut; E Van Cutsem; W De Wever; M Peeters; S Stroobants; P Dupont; G Bormans; M Hiele; P De Leyn; D Van Raemdonck; W Coosemans; N Ectors; K Haustermans; L Mortelmans
Journal:  J Clin Oncol       Date:  2000-09-15       Impact factor: 44.544

4.  Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.

Authors:  M P Stokkel; F W ten Broek; G J Hordijk; R Koole; P P van Rijk
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

5.  Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.

Authors:  T Kawamura; T Kusakabe; T Sugino; K Watanabe; T Fukuda; A Nashimoto; K Honma; T Suzuki
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

6.  Preoperative staging of non-small-cell lung cancer with positron-emission tomography.

Authors:  R M Pieterman; J W van Putten; J J Meuzelaar; E L Mooyaart; W Vaalburg; G H Koëter; V Fidler; J Pruim; H J Groen
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

7.  Japanese Classification of Gastric Carcinoma - 2nd English Edition -

Authors: 
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

Review 8.  Positron emission tomography in colorectal cancer.

Authors:  Patrick Flamen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-04       Impact factor: 3.043

9.  Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.

Authors:  Erito Mochiki; Hiroyuki Kuwano; Hiroyuki Katoh; Takayuki Asao; Noboru Oriuchi; Keigo Endo
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

10.  Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67.

Authors:  K Kubota; K Ishiwata; R Kubota; S Yamada; M Tada; T Sato; T Ido
Journal:  J Nucl Med       Date:  1991-11       Impact factor: 10.057

View more
  53 in total

Review 1.  Imaging in assessing lymph node status in gastric cancer.

Authors:  Robert Michael Kwee; Thomas Christian Kwee
Journal:  Gastric Cancer       Date:  2009-04-24       Impact factor: 7.370

2.  PET imaging for Treatment Response in Cancer.

Authors:  Janet F Eary
Journal:  PET Clin       Date:  2008-01-01

Review 3.  The role of ¹⁸F-FDG PET imaging in upper gastrointestinal malignancies.

Authors:  Tong Dai; Elizabeta Popa; Manish A Shah
Journal:  Curr Treat Options Oncol       Date:  2014-09

Review 4.  Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET/CT.

Authors:  Mijin Yun
Journal:  J Gastric Cancer       Date:  2014-03-31       Impact factor: 3.720

5.  Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey.

Authors:  Ryogo Minamimoto; Michio Senda; Seishi Jinnouchi; Takashi Terauchi; Tsuyoshi Yoshida; Tomio Inoue
Journal:  Jpn J Radiol       Date:  2014-02-23       Impact factor: 2.374

Review 6.  Is endoscopic ultrasonography still the modality of choice in preoperative staging of gastric cancer?

Authors:  Sung Wook Hwang; Dong Ho Lee
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 7.  Preoperative staging of nodal status in gastric cancer.

Authors:  Felix Berlth; Seung-Hun Chon; Mickael Chevallay; Minoa Karin Jung; Stefan Paul Mönig
Journal:  Transl Gastroenterol Hepatol       Date:  2017-02-07

8.  Incremental diagnostic utility of gastric distension FDG PET/CT.

Authors:  Pierre-Yves Le Roux; Cuong P Duong; Carlos S Cabalag; Bimal K Parameswaran; Jason Callahan; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-21       Impact factor: 9.236

9.  Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.

Authors:  Reiko Kameyama; Yuka Yamamoto; Kunihiko Izuishi; Ryusuke Takebayashi; Masanobu Hagiike; Makiko Murota; Masato Kaji; Reiji Haba; Yoshihiro Nishiyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236

Review 10.  Predicting lymph node status in early gastric cancer.

Authors:  Robert Michael Kwee; Thomas Christian Kwee
Journal:  Gastric Cancer       Date:  2008-09-30       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.